Skip to main content
. 1998 Apr 18;316(7139):1200–1205. doi: 10.1136/bmj.316.7139.1200

Table 4.

Changes from baseline value in measures of efficacy of treatments for visceral leishmaniasis on day 21 (end of aminosidine treatment) and day 30 (end of sodium stibogluconate treatment) after start of treatment. Values are mean (SD) unless stated otherwise

Aminosidine on day 21
Sodium stibogluconate 20 mg/kg/day (n=30)
Comparison (P value)*
12 mg/kg/day (n=30) 16 mg/kg/day (n=30) 20 mg/kg/day (n=30) Day 21 Day 30 Day 21 End of treatment
Body weight (kg) 2.10 (1.82) 2.40 (1.90) 2.00 (1.57) 2.03 (1.84) 2.55 (1.82) 0.82  0.60
Fever (°C) −1.64 (0.47)  −1.82 (0.60) −1.75 (0.42)  −1.33 (0.94) −1.46 (0.91)  0.023 0.14
Spleen size (cm) −4.12 (1.91)  −4.75 (2.56)   −5.1 (3.83)  −2.5 (2.57) −2.88 (3.12)  0.0032  0.023
Haemoglobin concentration (g/l) 17.9 (10.2)  24.1 (16.1) 21.0 (8.9)  12.5 (12.6) 16.3 (15.8) 0.003 0.11
White cell count (109/l)   3.05 (1.50)   3.44 (1.48)   3.12 (1.30)  1.79 (1.48)  1.90 (1.85) 0.001  0.001
Platelet count (109/l) 110 (96)  122 (74)  142 (79)  82 (70) 100 (89)  0.037 0.25
Albumin concentration (g/l)  9.1 (3.8)  8.9 (3.7)  9.8 (3.5)  5.8 (6.3) 7.8 (8.1) 0.004 0.54
Parasite burden (grade)  −2.07 (0.87)  −1.97 (0.93)  −2.30 (0.75) −1.30 (0.91) −1.23 (1.14)  0.0002  0.002
*

Comparison between groups done by one way analysis of variance with post hoc Tukey’s honest significance difference.  

Significant differences between groups on day 21.  

Significant differences between groups at end of treatment.